Trade ImmunityBio, Inc. - IBRX CFD
What is ImmunityBio, Inc. (IBRX)?
ImmunityBio, Inc. is a biotechnology company engaged in the development of immunotherapies and vaccines. Its research focuses on harnessing the immune system to treat diseases such as cancer and infectious diseases. The company utilizes proprietary platforms to develop novel therapeutic candidates aimed at enhancing immune responses. ImmunityBio’s pipeline includes products targeting various indications, including oncology and viral infections. The company collaborates with academic institutions and industry partners to advance its research and development efforts. Its approach combines immuno-oncology, cell therapy, and vaccine technologies to create treatments that stimulate or modulate immune function. ImmunityBio operates within the biopharmaceutical sector, contributing to the development of innovative therapies intended to address unmet medical needs.
ImmunityBio, Inc. Stock Price Today: Live Overview
The price today is shaped by ImmunityBio, Inc.'s latest trading activity, currently priced at $7.5. It has moved within the range of $7.39 to $8.24, with a daily move of -8.9571%.
FAQ: ImmunityBio, Inc. (IBRX)
What is the current price of IBRX stock?
The current stock price stands at $7.5.
Does IBRX pay dividends?
ImmunityBio, Inc. does not pay dividends.
Does IBRX have a formal corporate presence or regional headquarters in the UAE?
ImmunityBio, Inc. does not have an official regional office or subsidiary in the UAE and operates through partners or distributors.
What is IBRX best known for?
The company is most famous for its development of immunotherapy treatments.
What assets are typically shown together with IBRX?
Commonly shown alongside IBRX: Lonza Group Ltd, Nexi SpA, Horizon Robotics
Latest shares articles



